126 related articles for article (PubMed ID: 7505231)
1. Neoadjuvant hormonal deprivation before radical prostatectomy.
Sassine AM; Schulman CC
Eur Urol; 1993; 24 Suppl 2():46-50. PubMed ID: 7505231
[TBL] [Abstract][Full Text] [Related]
2. Neoadjuvant hormonal deprivation before radical prostatectomy.
Schulman CC; Sassine AM
Eur Urol; 1993; 24(4):450-5. PubMed ID: 7507045
[TBL] [Abstract][Full Text] [Related]
3. Neoadjuvant hormonal deprivation before radical prostatectomy.
Schulman CC; Sassine AM
Clin Invest Med; 1993 Dec; 16(6):523-31. PubMed ID: 7516836
[TBL] [Abstract][Full Text] [Related]
4. Neoadjuvant androgen blockade prior to prostatectomy: a retrospective study and critical review.
Schulman CC
Prostate Suppl; 1994; 5():9-14. PubMed ID: 7513532
[TBL] [Abstract][Full Text] [Related]
5. High failure rate associated with long-term follow-up of neoadjuvant androgen deprivation followed by radical prostatectomy for stage C prostatic cancer.
Cher ML; Shinohara K; Breslin S; Vapnek J; Carroll PR
Br J Urol; 1995 Jun; 75(6):771-7. PubMed ID: 7542137
[TBL] [Abstract][Full Text] [Related]
6. [Effect of complete androgen block before radical prostatectomy for cancer of the prostate].
Gómez Veiga F; Lorenzo Patiño MJ; Díaz Bermúdez J; Duarte Novo J; Alvarez Castelo L; Chantada Abal V; Sánchez Rodríguez J; González Martín M
Arch Esp Urol; 1997 May; 50(4):355-63. PubMed ID: 9313044
[TBL] [Abstract][Full Text] [Related]
7. Preliminary results of a prospective randomized study comparing radical prostatectomy versus radical prostatectomy associated with neoadjuvant hormonal combination therapy in T2-3 N0 M0 prostatic carcinoma. The European Study Group on Neoadjuvant Treatment of Prostate Cancer.
Witjes WP; Schulman CC; Debruyne FM
Urology; 1997 Mar; 49(3A Suppl):65-9. PubMed ID: 9123739
[TBL] [Abstract][Full Text] [Related]
8. Significance of androgen deprivation prior to radical prostatectomy, with special reference to prostate-specific antigen.
Soloway MS; Hachiya T; Ruiz HE; Gomez CC; Civantos F
World J Urol; 1993; 11(4):221-6. PubMed ID: 7508788
[TBL] [Abstract][Full Text] [Related]
9. PSA levels and the rate of positive surgical margins in radical prostatectomy specimens preceded by androgen blockade in clinical B2 (T2bNxMo) prostate cancer. The Lupron Depot Neoadjuvant Study Group.
McLeod DG; Johnson CF; Klein E; Peabody JO; Coffield S; Soloway M
Urology; 1997 Mar; 49(3A Suppl):70-3. PubMed ID: 9123740
[TBL] [Abstract][Full Text] [Related]
10. Effects of androgen deprivation prior to radical prostatectomy in 375 patients.
Tunn UW; Acar O; Goldschmidt AJ
Urol Int; 1996; 56 Suppl 1():6-12. PubMed ID: 8776811
[TBL] [Abstract][Full Text] [Related]
11. [Prognostic factors in patients with prostatic cancer treated with neoadjuvant hormonal therapy and radical prostatectomy].
Villavicencio Mavrich H; Chéchile Toniolo G; Salinas Duffo D; Muñoz Plaza J; Sorraca Ibáñez YJ
Arch Esp Urol; 1996 Oct; 49(8):797-806. PubMed ID: 9065276
[TBL] [Abstract][Full Text] [Related]
12. Androgen deprivation prior to radical prostatectomy for T2b and T3 prostate cancer.
Soloway MS; Hachiya T; Civantos F; Murphy WM; Gomez CC; Ruiz HE
Urology; 1994 Feb; 43(2 Suppl):52-6. PubMed ID: 7509535
[TBL] [Abstract][Full Text] [Related]
13. Preoperative androgen deprivation therapy: artificial lowering of serum prostate specific antigen without downstaging the tumor.
Oesterling JE; Andrews PE; Suman VJ; Zincke H; Myers RP
J Urol; 1993 Apr; 149(4):779-82. PubMed ID: 7681117
[TBL] [Abstract][Full Text] [Related]
14. Randomized comparative study of 3 versus 8-month neoadjuvant hormonal therapy before radical prostatectomy: biochemical and pathological effects.
Gleave ME; Goldenberg SL; Chin JL; Warner J; Saad F; Klotz LH; Jewett M; Kassabian V; Chetner M; Dupont C; Van Rensselaer S;
J Urol; 2001 Aug; 166(2):500-6; discussion 506-7. PubMed ID: 11458055
[TBL] [Abstract][Full Text] [Related]
15. Biochemical and pathological effects of 8 months of neoadjuvant androgen withdrawal therapy before radical prostatectomy in patients with clinically confined prostate cancer.
Gleave ME; Goldenberg SL; Jones EC; Bruchovsky N; Sullivan LD
J Urol; 1996 Jan; 155(1):213-9. PubMed ID: 7490838
[TBL] [Abstract][Full Text] [Related]
16. [Predictive value of the serum PSA level in patients having undergone neo-adjuvant hormone treatment before radical prostatectomy].
Wildschutz T; Janssen T; Schulman C
Acta Urol Belg; 1995 Mar; 63(1):79-82. PubMed ID: 7537012
[TBL] [Abstract][Full Text] [Related]
17. Induction androgen deprivation therapy before radical prostatectomy for prostate cancer--initial results.
Abbas F; Kaplan M; Soloway MS
Br J Urol; 1996 Mar; 77(3):423-8. PubMed ID: 8814850
[TBL] [Abstract][Full Text] [Related]
18. 4-Year follow-up results of a European prospective randomized study on neoadjuvant hormonal therapy prior to radical prostatectomy in T2-3N0M0 prostate cancer. European Study Group on Neoadjuvant Treatment of Prostate Cancer.
Schulman CC; Debruyne FM; Forster G; Selvaggi FP; Zlotta AR; Witjes WP
Eur Urol; 2000 Dec; 38(6):706-13. PubMed ID: 11111188
[TBL] [Abstract][Full Text] [Related]
19. Maximum androgen deprivation prior to radical retropubic prostatectomy in patients with stage T3 adenocarcinoma of the prostate.
Voges GE; Mottrie AM; Fichtner J; Mappes C; Störkel S; Stöckle M; Hohenfellner R
Eur Urol; 1995; 28(3):209-14. PubMed ID: 8536774
[TBL] [Abstract][Full Text] [Related]
20. Neoadjuvant hormonal deprivation in patients with locally advanced prostate cancer.
Macfarlane MT; Abi-Aad A; Stein A; Danella J; Belldegrun A; deKernion JB
J Urol; 1993 Jul; 150(1):132-4. PubMed ID: 7685421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
